After 72 h of co-culturing CD19+ cells with autologous CD14+ cells, the frequency (%) of alive CD19+ cells was higher in both CLL patients and healthy donors compared to CD19+ cells cultured alone (Figure 3A,B). This evidence concerns the gene CD14 and B-cell chronic lymphocytic leukemia.